LV2B_MOUSE
ID LV2B_MOUSE Reviewed; 129 AA.
AC P01729;
DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT 21-JUL-1986, sequence version 1.
DT 25-MAY-2022, entry version 114.
DE RecName: Full=Ig lambda-2 chain V region MOPC 315;
DE Flags: Precursor;
OS Mus musculus (Mouse).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Mus; Mus.
OX NCBI_TaxID=10090;
RN [1]
RP NUCLEOTIDE SEQUENCE.
RX PubMed=6287422; DOI=10.1093/nar/10.13.3831;
RA Wu G.E., Govindji N., Hozumi N., Murialdo H.;
RT "Nucleotide sequence of a chromosomal rearranged lambda 2 immunoglobulin
RT gene of mouse.";
RL Nucleic Acids Res. 10:3831-3843(1982).
RN [2]
RP NUCLEOTIDE SEQUENCE.
RX PubMed=6283385; DOI=10.1038/298380a0;
RA Bothwell A.L.M., Paskind M., Reth M., Imanishi-Kari T., Rajewsky K.,
RA Baltimore D.;
RT "Somatic variants of murine immunoglobulin lambda light chains.";
RL Nature 298:380-382(1982).
RN [3]
RP PROTEIN SEQUENCE OF 1-22 (PRECURSOR PROTEIN).
RX PubMed=428562;
RA Schechter I., Wolf O., Zemell R., Burstein Y.;
RT "Structure and function of immunoglobulin genes and precursors.";
RL Fed. Proc. 38:1839-1845(1979).
RN [4]
RP PROTEIN SEQUENCE OF 20-129.
RX PubMed=4760498;
RA Dugan E.S., Bradshaw R.A., Simms E.S., Eisen H.N.;
RT "Amino acid sequence of the light chain of a mouse myeloma protein (MOPC-
RT 315).";
RL Biochemistry 12:5400-5416(1973).
RN [5]
RP DETERMINATION OF AMIDATION STATES OF 58; 59; 62; 100; 102 AND 115.
RX PubMed=418802; DOI=10.1021/bi00600a032;
RA Gavish M., Zakut R., Wilchek M., Givol D.;
RT "Preparation of a semisynthetic antibody.";
RL Biochemistry 17:1345-1351(1978).
CC -!- MISCELLANEOUS: This chain is from a myeloma protein with anti-DNP
CC activity.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR PIR; A27633; A27633.
DR PIR; A93431; L2MS35.
DR PIR; PL0192; PL0192.
DR AlphaFoldDB; P01729; -.
DR SMR; P01729; -.
DR MaxQB; P01729; -.
DR PRIDE; P01729; -.
DR PhylomeDB; P01729; -.
DR Proteomes; UP000000589; Unplaced.
DR RNAct; P01729; protein.
DR GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR GO; GO:0019814; C:immunoglobulin complex; IEA:UniProtKB-KW.
DR GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR GO; GO:0006955; P:immune response; IBA:GO_Central.
DR Gene3D; 2.60.40.10; -; 1.
DR InterPro; IPR007110; Ig-like_dom.
DR InterPro; IPR036179; Ig-like_dom_sf.
DR InterPro; IPR013783; Ig-like_fold.
DR InterPro; IPR003599; Ig_sub.
DR InterPro; IPR013106; Ig_V-set.
DR Pfam; PF07686; V-set; 1.
DR SMART; SM00409; IG; 1.
DR SMART; SM00406; IGv; 1.
DR SUPFAM; SSF48726; SSF48726; 1.
DR PROSITE; PS50835; IG_LIKE; 1.
PE 1: Evidence at protein level;
KW Adaptive immunity; Direct protein sequencing; Immunity; Immunoglobulin;
KW Pyrrolidone carboxylic acid; Reference proteome; Signal.
FT SIGNAL 1..19
FT /evidence="ECO:0000269|PubMed:4760498,
FT ECO:0000269|PubMed:6287422"
FT CHAIN 20..129
FT /note="Ig lambda-2 chain V region MOPC 315"
FT /id="PRO_0000015206"
FT DOMAIN 20..125
FT /note="Ig-like"
FT MOD_RES 20
FT /note="Pyrrolidone carboxylic acid"
FT /evidence="ECO:0000250|UniProtKB:P01724"
FT NON_TER 129
SQ SEQUENCE 129 AA; 13418 MW; 0AA6E8125723552C CRC64;
MAWTSLILSL LALCSGASSQ AVVTQESALT TSPGGTVILT CRSSTGAVTT SNYANWIQEK
PDHLFTGLIG GTSNRAPGVP VRFSGSLIGD KAALTITGAQ TEDDAMYFCA LWFRNHFVFG
GGTKVTVLG